STAT published a wide range of stories on health and medicine this year, covering topics such as the killing of a health insurance executive, UnitedHealth’s questionable practices, CRISPR advancements, GLP-1 therapies, vaccine policies under the new administration, AI in healthcare, drug patents, food as medicine, drug companies’ pricing strategies, and more. The coverage also delved into the challenges of achieving health equity, advancements in the life sciences, and the ups and downs of biotech and pharma companies. The year’s reporting highlighted the complexities and advancements in the healthcare industry while exploring critical issues affecting patients, researchers, and the industry as a whole.
Source link
Top health, life science and medical stories of 2024
